Do either of these products concern anybody? From what I read the rapid inhaled will be limited due to pulmonary and the long acting is pretty much a super-lantus so managed care will restrict use.
Sound about right?
I heard sanofi is ramping up, hiring reps like crazy and I don't really get why. Maybe something else the field will be carrying at some point?
Just curious.
Sound about right?
I heard sanofi is ramping up, hiring reps like crazy and I don't really get why. Maybe something else the field will be carrying at some point?
Just curious.
Toujeo or Affrezza
Aucun commentaire:
Enregistrer un commentaire